FRANK MALENSEK: Open Payments
NPI 1598739500 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$93 in 6 payments from 4 companies in 2025. Trend: 2023 $166 · 2024 $87 · 2025 $93
Food & beverage: $93
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $42 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Pharmacosmos Therapeutics Inc. | 1 | $15 |
Products named: REPATHA, Qelbree, AREXVY, MONOFERRIC, OTEZLA.
Industry payments across AL — which companies pay providers there.
